ALVAC-prime and monomeric gp120 protein boost induces distinct HIV-1 specific humoral and cellular responses compared with adenovirus-prime and trimeric gp140 protein boost.
Saved in:
| Title: | ALVAC-prime and monomeric gp120 protein boost induces distinct HIV-1 specific humoral and cellular responses compared with adenovirus-prime and trimeric gp140 protein boost. |
|---|---|
| Authors: | Fisher LH; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Lazarus E; Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa., Yu C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Moodie Z; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Stieh DJ; Janssen Vaccines & Prevention, Leiden, The Netherlands., Yates N; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, United States of America., Zhang L; Duke University, Durham, North Carolina, United States of America., Sawant S; Duke University, Durham, North Carolina, United States of America., De Rosa SC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Cohen KW; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Morris D; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Grant S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Randhawa A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Miner MD; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Hendriks J; Janssen Vaccines & Prevention, Leiden, The Netherlands., Wegmann F; Janssen Vaccines & Prevention, Leiden, The Netherlands., Gill KM; The Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa., Laher F; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Soweto, South Africa., Bekker LG; The Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa., Gray GE; South African Medical Research Council, Cape Town, South Africa., Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Martin T; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America., Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Department of Biostatistics, University of Washington, Seattle, Washington, United States of America., Tomaras G; Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.; Department of Immunology, Duke University Medical Center, Durham, North Carolina, United States of America.; Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, United States of America., Walsh SR; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.; Harvard Medical School, Boston, Massachusetts, United States of America.; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America., Baden LR; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.; Harvard Medical School, Boston, Massachusetts, United States of America. |
| Corporate Authors: | HVTN 100, HVTN 117/HPX2004 study teams |
| Source: | PLOS global public health [PLOS Glob Public Health] 2025 Apr 11; Vol. 5 (4), pp. e0004250. Date of Electronic Publication: 2025 Apr 11 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 9918283779606676 Publication Model: eCollection Cited Medium: Internet ISSN: 2767-3375 (Electronic) Linking ISSN: 27673375 NLM ISO Abbreviation: PLOS Glob Public Health Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40215224 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: ALVAC-prime and monomeric gp120 protein boost induces distinct HIV-1 specific humoral and cellular responses compared with adenovirus-prime and trimeric gp140 protein boost. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Fisher+LH%22">Fisher LH</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Lazarus+E%22">Lazarus E</searchLink>; Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.<br /><searchLink fieldCode="AU" term="%22Yu+C%22">Yu C</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Moodie+Z%22">Moodie Z</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Stieh+DJ%22">Stieh DJ</searchLink>; Janssen Vaccines & Prevention, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Yates+N%22">Yates N</searchLink>; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22Zhang+L%22">Zhang L</searchLink>; Duke University, Durham, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22Sawant+S%22">Sawant S</searchLink>; Duke University, Durham, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22De+Rosa+SC%22">De Rosa SC</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Cohen+KW%22">Cohen KW</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Morris+D%22">Morris D</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Grant+S%22">Grant S</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Randhawa+A%22">Randhawa A</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Miner+MD%22">Miner MD</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Hendriks+J%22">Hendriks J</searchLink>; Janssen Vaccines & Prevention, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Wegmann+F%22">Wegmann F</searchLink>; Janssen Vaccines & Prevention, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Gill+KM%22">Gill KM</searchLink>; The Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Laher+F%22">Laher F</searchLink>; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Soweto, South Africa.<br /><searchLink fieldCode="AU" term="%22Bekker+LG%22">Bekker LG</searchLink>; The Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Gray+GE%22">Gray GE</searchLink>; South African Medical Research Council, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Corey+L%22">Corey L</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22McElrath+MJ%22">McElrath MJ</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Martin+T%22">Martin T</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Gilbert+PB%22">Gilbert PB</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Department of Biostatistics, University of Washington, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Tomaras+G%22">Tomaras G</searchLink>; Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.; Department of Immunology, Duke University Medical Center, Durham, North Carolina, United States of America.; Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22Walsh+SR%22">Walsh SR</searchLink>; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.; Harvard Medical School, Boston, Massachusetts, United States of America.; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Baden+LR%22">Baden LR</searchLink>; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.; Harvard Medical School, Boston, Massachusetts, United States of America. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22HVTN+100%2C+HVTN+117%2FHPX2004+study+teams%22">HVTN 100, HVTN 117/HPX2004 study teams</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229918283779606676%22">PLOS global public health</searchLink> [PLOS Glob Public Health] 2025 Apr 11; Vol. 5 (4), pp. e0004250. <i>Date of Electronic Publication: </i>2025 Apr 11 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9918283779606676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2767-3375 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2227673375%22">27673375 </searchLink><i>NLM ISO Abbreviation: </i>PLOS Glob Public Health <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40215224 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pgph.0004250 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e0004250 Titles: – TitleFull: ALVAC-prime and monomeric gp120 protein boost induces distinct HIV-1 specific humoral and cellular responses compared with adenovirus-prime and trimeric gp140 protein boost. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Fisher LH – PersonEntity: Name: NameFull: Lazarus E – PersonEntity: Name: NameFull: Yu C – PersonEntity: Name: NameFull: Moodie Z – PersonEntity: Name: NameFull: Stieh DJ – PersonEntity: Name: NameFull: Yates N – PersonEntity: Name: NameFull: Zhang L – PersonEntity: Name: NameFull: Sawant S – PersonEntity: Name: NameFull: De Rosa SC – PersonEntity: Name: NameFull: Cohen KW – PersonEntity: Name: NameFull: Morris D – PersonEntity: Name: NameFull: Grant S – PersonEntity: Name: NameFull: Randhawa A – PersonEntity: Name: NameFull: Miner MD – PersonEntity: Name: NameFull: Hendriks J – PersonEntity: Name: NameFull: Wegmann F – PersonEntity: Name: NameFull: Gill KM – PersonEntity: Name: NameFull: Laher F – PersonEntity: Name: NameFull: Bekker LG – PersonEntity: Name: NameFull: Gray GE – PersonEntity: Name: NameFull: Corey L – PersonEntity: Name: NameFull: McElrath MJ – PersonEntity: Name: NameFull: Martin T – PersonEntity: Name: NameFull: Gilbert PB – PersonEntity: Name: NameFull: Tomaras G – PersonEntity: Name: NameFull: Walsh SR – PersonEntity: Name: NameFull: Baden LR IsPartOfRelationships: – BibEntity: Dates: – D: 11 M: 04 Text: 2025 Apr 11 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2767-3375 Numbering: – Type: volume Value: 5 – Type: issue Value: 4 Titles: – TitleFull: PLOS global public health Type: main |
| ResultId | 1 |
